Risk factors and pathophysiology of chronic obstructive pulmonary disease (COPD)

Journal of Association of Physicians of India

Volumn 60, Issue SUPPL FEB2012, 2012, Pages 17-21

  Brashier, Bill B ^a   Kodgule, Rahul ^b  

^a Head Molecular and Clinical Research   (India)

^b Chest Research Foundation   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AGE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; GENETIC POLYMORPHISM; GENETICS; HUMAN; INFLAMMATION; LUNG; PATHOPHYSIOLOGY; POLLUTION; PULMONARY HYPERTENSION; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; SOCIOECONOMICS;

AGE FACTORS; BIOLOGICAL MARKERS; COMORBIDITY; ENVIRONMENTAL POLLUTION; HUMANS; HYPERTENSION, PULMONARY; INFLAMMATION; LUNG; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 84871881693     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Mannino DM, Buist AS. Global burden of COPD: risk factor prevalence, and future trends. Lancet 2007;370:765-73.
2. Viegi G, Pistelli F, Sherrill DL et al Definition, epidemiology and natural history of COPD. SERIES "COMPREHENSIVE MANAGEMENT OF END-STAGE COPD" Edited by N. Ambrosino and R. Goldstein Number 1 in this Series. Eur Respir J 2007;30:993-1013.
3. Mannino DM, Watt G, Hole D, et al. The natural history of chronic obstructive pulmonary disease. Eur Respir J 2006;27:627-43.
4. Rennard SI, Vestbo J. COPD: the dangerous underestimate of 15%. Lancet 2006;367:1216-19.
5. Lundback B, Lindberg A, Lindstrom M, et al. Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003;97:115-22.
6. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in nonsmokers. Lancet 2009;374:733-43.
7. Salvi SS, Barnes PJ. Is exposure to biomass smoke the biggest risk factor for COPD globally? Chest 2010;138:3-6.
8. Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet. 2005;365:2225-36.
9. Wan ES, Silverman EK. Genetics of COPD and Emphysema. Chest 2009;136:859-866.
10. Nakamura H. Genetics of COPD. Allergol Int 2011. Jul 25 (Epub ahead of print) http://chestjournal.chestpubs.org/externalref?access_num=10.3109/00365516309051324andlink_type=DOI
11. Stockley RA; Neutrophils and the Pathogenesis of COPD. Chest 2002;121:151S-155S.
12. Tetley TD. Macrophages and the Pathogenesis of COPD. Chest 2002;121:156S-159S.
13. Barnes PJ, Cosio MG. Characterization of T Lymphocytes in Chronic Obstructive Pulmonary Disease PLoS Medicine 2004;1:e20.
14. William MacNee, MD. Oxidants/Antioxidants and COPD. Chest 2000;117:303S-317S
15. Shapiro S. The pathophysiology of COPD: What go wrong and why? Proceedings. Adv Stud Med 2003;3(2B): S91-S98.
16. Calverly PMA. Dynamic Hyperinflation: Is it worth measuring? Proc Am Thorac Soc 2006;3:239-244.
17. Global initiative for Chronic Obstructive Lung Disease (GOLD). 2009 Update. www.goldcopd.org.
18. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Series "Pulmonary Hypertension: Basic Concepts for Practical Management" Number 6 in this Series. Eur Respir J 2008;32:1371-1385.
19. Yanbaeva DG, Dentener MA, Creutzberg EC, Wouters EF. Systemic inflammation in COPD: is genetic susceptibility a key factor? COPD 2006;3:51-61.
20. Pinto-Plata VM, Mullerova H, Toso JF et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 2006;61:23-28.
21. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007;370:797-799.
22. Fabbri LM, Beghe B, Agusti A Cardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guidelines. Thorax 2011;1e3.
23. Chang CL, Robinson SC, Mills GD, et al. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax. Published Online First: 7 April 2011. doi:10.1136/ thx.2010.155333.
24. Hoiseth AD, Neukam A, Karlsson D, et al. Elevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease. Thorax. Published Online First. doi:10.1136/thx.2010.153122.
25. Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J 2008;31:204-212